Male Infertility - Pipeline Review, H1 2018

SKU ID :GMD-11171702 | Published Date: 13-Mar-2018 | No. of pages: 37
Table of Contents List of Tables List of Figures Introduction Global Markets Direct Report Coverage Male Infertility - Overview Male Infertility - Therapeutics Development Pipeline Overview Pipeline by Companies Pipeline by Universities/Institutes Products under Development by Companies Products under Development by Universities/Institutes Male Infertility - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Male Infertility - Companies Involved in Therapeutics Development Cadila Healthcare Ltd Ferring International Center SA Health Ever Bio-Tech Co Ltd Navya Biologicals Pvt Ltd Male Infertility - Drug Profiles Biosimilar 5 for Infertility and Oncology - Drug Profile Product Description Mechanism Of Action R&D Progress Biosimilar 6 for Infertility, Oncology and Immunology - Drug Profile Product Description Mechanism Of Action R&D Progress Biosimilar 7 for Infertility, Immunology, Infectious Disease and Oncology - Drug Profile Product Description Mechanism Of Action R&D Progress FE-999310 - Drug Profile Product Description Mechanism Of Action R&D Progress follicle stimulating hormone biobetter - Drug Profile Product Description Mechanism Of Action R&D Progress LM-001 - Drug Profile Product Description Mechanism Of Action R&D Progress LM-002 - Drug Profile Product Description Mechanism Of Action R&D Progress MCS-5 - Drug Profile Product Description Mechanism Of Action R&D Progress NAV-013 - Drug Profile Product Description Mechanism Of Action R&D Progress PAM-8 - Drug Profile Product Description Mechanism Of Action R&D Progress pentoxifylline - Drug Profile Product Description Mechanism Of Action R&D Progress Recombinant Enzyme to Replace Beta Glucosidase 2 for Gaucher's Disease and Male Infertility - Drug Profile Product Description Mechanism Of Action R&D Progress trequinsin - Drug Profile Product Description Mechanism Of Action R&D Progress Male Infertility - Dormant Projects Appendix Methodology Coverage Secondary Research Primary Research Expert Panel Validation Contact Us Disclaimer
List of Tables Number of Products under Development for Male Infertility, H1 2018 Number of Products under Development by Companies, H1 2018 Number of Products under Development by Universities/Institutes, H1 2018 Products under Development by Companies, H1 2018 Products under Development by Universities/Institutes, H1 2018 Number of Products by Stage and Target, H1 2018 Number of Products by Stage and Mechanism of Action, H1 2018 Number of Products by Stage and Route of Administration, H1 2018 Number of Products by Stage and Molecule Type, H1 2018 Male Infertility - Pipeline by Cadila Healthcare Ltd, H1 2018 Male Infertility - Pipeline by Ferring International Center SA, H1 2018 Male Infertility - Pipeline by Health Ever Bio-Tech Co Ltd, H1 2018 Male Infertility - Pipeline by Navya Biologicals Pvt Ltd, H1 2018 Male Infertility - Dormant Projects, H1 2018List of Figures Number of Products under Development for Male Infertility, H1 2018 Number of Products under Development by Companies, H1 2018 Number of Products under Development by Universities/Institutes, H1 2018 Number of Products by Targets, H1 2018 Number of Products by Stage and Targets, H1 2018 Number of Products by Mechanism of Actions, H1 2018 Number of Products by Stage and Mechanism of Actions, H1 2018 Number of Products by Routes of Administration, H1 2018 Number of Products by Stage and Routes of Administration, H1 2018 Number of Products by Molecule Types, H1 2018 Number of Products by Stage and Molecule Types, H1 2018
  • PRICE
  • $2000
    $6000

Our Clients